Showing results (1-10 of 526) with videos related to
Sort By:
Pageof 53
Clinical Pharmacology and Therapeutics|August 1, 1983
Variation in amobarbital metabolism: evaluation of a simplified population studyB K Tang, W Kalow, T Inaba, et al.Clinical Pharmacology and Therapeutics|November 1, 1978
Distinctive patterns of amobarbital metabolitesW Kalow, B K Tang, D Kadar, et al.Clinical Pharmacology and Therapeutics|May 1, 1977
A case of deficiency of N-hydroxylation of amobarbitalW Kalow, D Kadar, T Inaba, et al.Clinical Pharmacology and Therapeutics|November 1, 1987
An alternative test for acetylator phenotyping with caffeineB K Tang, D Kadar, W KalowResearch Communications in Chemical Pathology and Pharmacology|May 1, 1981
Antipyrine metabolites in two populationsT Inaba, H Uchino, D Kadar, et al.British Journal of Clinical Pharmacology|April 1, 1985
Genetic polymorphism of mephenytoin p(4')-hydroxylation: difference between Orientals and CaucasiansM Jurima, T Inaba, D Kadar, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1975
N-hydroxyamobarbital: the second major metabolite of amobarbital in manB K Tang, T Inaba, W KalowDrug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1977
N-Hydroxylation of pentobarbital in manB K Tang, T Inaba, W KalowPharmacogenetics|June 1, 1994
Caffeine as a probe for CYP1A2 activity: potential influence of renal factors on urinary phenotypic trait measurementsB K Tang, Y Zhou, D Kadar, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1989
In vitro studies of human liver alcohol dehydrogenase variants using a variety of substratesJ P Kassam, B K Tang, D Kadar, et al.Pageof 53